Anzeige
Mehr »
Montag, 20.10.2025 - Börsentäglich über 12.000 News
Homeland Uranium: Vom Geheimtipp zum potenziellen Entwicklerstar
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A2QPKG | ISIN: US29415V1098 | Ticker-Symbol:
NASDAQ
20.10.25 | 16:41
0,830 US-Dollar
-0,90 % -0,008
Branche
Gesundheitswesen
Aktienmarkt
Sonstige
1-Jahres-Chart
ENVOY MEDICAL INC Chart 1 Jahr
5-Tage-Chart
ENVOY MEDICAL INC 5-Tage-Chart

Aktuelle News zur ENVOY MEDICAL Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
FrEnvoy Medical, Inc. - S-1, General form for registration of securities-
09.10.Envoy Medical, Inc.: Envoy Medical Announces Closing of Up to $16 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules340White Bear Lake, Minnesota--(Newsfile Corp. - October 9, 2025) - Envoy Medical® Inc. (NASDAQ: COCH) ("Envoy Medical"), a hearing health company focused on developing innovative, fully implanted hearing...
► Artikel lesen
08.10.Envoy Medical stock plunges after announcing $4 million offering1
08.10.Envoy Medical secures $4M upfront in direct offering, targets total $16M via warrant exercise1
08.10.Envoy Medical raises $4 million in direct offering to fund operations1
08.10.Envoy Medical, Inc.: Envoy Medical Announces up to $16 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules192White Bear Lake, Minnesota--(Newsfile Corp. - October 8, 2025) - Envoy Medical® Inc. (NASDAQ: COCH) ("Envoy Medical"), a hearing health company focused on developing innovative, fully implanted hearing...
► Artikel lesen
07.10.Envoy Medical, Inc. - 8-K, Current Report5
07.10.Envoy Medical: Aktie schießt nach FDA-Genehmigung für Studienerweiterung in die Höhe3
ENVOY MEDICAL Aktie jetzt für 0€ handeln
07.10.Envoy Medical stock soars after FDA approves clinical trial expansion4
07.10.FDA genehmigt Erweiterung der Implantat-Studie von Envoy Medical5
07.10.Envoy Medical, Inc.: Envoy Medical Receives FDA Approval to Advance Its Pivotal Clinical Trial to Final Stage Based on Submission of Promising Three-Month Data272White Bear Lake, Minnesota--(Newsfile Corp. - October 7, 2025) - Envoy Medical, Inc. (NASDAQ: COCH) ("Envoy Medical" or the "Company"), a hearing health company pioneering fully implanted hearing solutions...
► Artikel lesen
07.10.EXCLUSIVE: Envoy Medical Cuts Capital Needs After FDA Approval For Final Trial Stage Of Cochlear Implant Trial3
01.10.Envoy Medical, Inc.: Envoy Medical to Participate in the American Academy of Otolaryngology Head and Neck Surgery (AAO-HNSF) Conference on October 11th-14th189White Bear Lake, Minnesota--(Newsfile Corp. - October 1, 2025) - Envoy Medical® Inc. (NASDAQ: COCH) ("Envoy Medical"), a hearing health company focused on developing innovative, fully implanted hearing...
► Artikel lesen
25.09.Envoy Medical closes $2.5 million registered direct offering3
25.09.Envoy Medical, Inc.: Envoy Medical Announces Closing of $2.5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules247White Bear Lake, Minnesota--(Newsfile Corp. - September 25, 2025) - Envoy Medical® Inc. (NASDAQ: COCH) ("Envoy Medical"), a hearing health company focused on developing innovative, fully implanted...
► Artikel lesen
24.09.Envoy Medical, Inc.: Envoy Medical Advances Commercialization Planning for Breakthrough Hearing Device as FDA Clinical Trial Remains On Track199The Company Begins Strategic Preparations To Support Anticipated Demand And Optimization Of The Acclaim® Fully Implanted Cochlear Implant OpportunitySix-month follow-up visits are now underway and...
► Artikel lesen
22.09.Envoy Medical announces $2.5 million registered direct offering priced at-the-market under Nasdaq rules2
22.09.Envoy Medical raises $2.5 million in registered direct offering1
22.09.Envoy Medical, Inc.: Envoy Medical Announces $2.5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules178White Bear Lake, Minnesota--(Newsfile Corp. - September 22, 2025) - Envoy Medical® Inc. (NASDAQ: COCH) ("Envoy Medical"), a hearing health company focused on developing innovative, fully implanted...
► Artikel lesen
19.09.Envoy Medical, Inc.: Envoy Medical Expands Patent Portfolio by Securing Additional European Patent for Breakthrough Cochlear Implant Technology408White Bear Lake, Minnesota--(Newsfile Corp. - September 19, 2025) - Envoy Medical® Inc. (NASDAQ: COCH) ("Envoy Medical"), a hearing health company focused on developing innovative, fully implanted...
► Artikel lesen
Weiter >>
62 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1